Slide1 en
Scientific excellence
MORE INFORMATION
Slide1 en
Slide2 en
We are committed to patients
MORE INFORMATION
Slide2 en
Slide3 en
Innovation
Innovation and user experience in healthcare technologies
MORE INFORMATION
Slide3 en
previous arrow
next arrow

Upcoming opening and presentation of IDIVAL’s NEXT-VAL 2026 Program

The Marqués de Valdecilla Research Institute (IDIVAL) announces the upcoming launch of the 2026 call for proposals of the NEXT-VAL Program, an initiative aimed at promoting the development of translational research projects within the biosanitary environment of Cantabria. The program is intended for emerging principal investigators who have not previously...

Más información

IDIVAL support programmes will exceed €1.5 million in 2026

The call, published in the Official Gazette of Cantabria (BOC) on February 18, 2026, promotes talent recruitment, innovation, internationalization, and patient-based studies. The Marqués de Valdecilla Research Institute (IDIVAL) has launched eight biomedical research promotion programmes under the 2026 call of the PLADIBIO programme, published in the Official Gazette of...

Más información

IDIVAL awarded “Best Healthcare Entity” at the 2025 New Medical Economics Awards

The Valdecilla Health Research Institute (IDIVAL) has been recognized as Best Healthcare Entity at the 2025 New Medical Economics Awards, which each year highlight excellence, innovation, and the healthcare sector’s commitment to society. Following an evaluation process that combined the scrutiny of its Editorial Board and the participation of its...

Más información

IMPaCT Cohort: a large study to improve the health of the Spanish population

Cohorte IMPaCT is an ambitious health study of the Instituto de Salud Carlos III coordinated by the Centro de Investigación Biomédica en Red (CIBER) that aims to monitor the health of 200,000 people living in Spain over 20 years. Cohorte IMPaCT is being developed thanks to the participation of all...

Más información

Newsletter